Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse

This study has been completed.
Information provided by:
Eli Lilly and Company Identifier:
First received: September 12, 2005
Last updated: November 5, 2007
Last verified: November 2007